跳至主要内容
临床试验/IRCT20210823052264N6
IRCT20210823052264N6招募中3 期

Comparison of efficacy of intramuscular meglumine antimoniate plus oral allopurinol with intramuscular meglumine antimoniate alone in treatment of cutaneous leishmaniasis

CMH Quetta0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • All patients with biopsy proven leishmaniasis or has lesion(s) located in sites not compatible with local treatment for example lesions on or around eyes
  • Disfiguring lesion on face that lead to scarring
  • Lesions difficult to heal like on lower limbs
  • Lesion more than 4cm in size with sporotichoid spread
  • Multiple lesions

排除标准

  • patients allergic to antimonials
  • Pregnant and breast feeding patients
  • Patients having mucosal, mucocutaneous or visceral leishmaniasis
  • Patients with comorbids (diabetes, hypertension, chronic liver disease, chronic kidney disease)
  • Immunosuppression patients
  • Baseline ECG abnormalities/heart disease

研究者

发起方
CMH Quetta

相似试验